The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 10 July 2006 doi:10.1084/jem.20051725
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 8, 1891-1901
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1902K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharif, M. N.
Right arrow Articles by Ivashkiv, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharif, M. N.
Right arrow Articles by Ivashkiv, L. B.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
*Genetics Home Reference
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Twist mediates suppression of inflammation by type I IFNs and Axl

M. Nusrat Sharif1, Drazen Sosic3, Carla V. Rothlin4, Erin Kelly1, Greg Lemke4, Eric N. Olson3, and Lionel B. Ivashkiv1,2

1 Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021
2 Graduate Program in Immunology, Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021
3 Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390
4 Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA 92037

CORRESPONDENCE Lionel B. Ivashkiv: ivashkivl{at}hss.edu

Type I interferons (IFNs) are pleiotropic cytokines with antiviral and immunomodulatory properties. The immunosuppressive actions of type I IFNs are poorly understood, but IFN-mediated suppression of TNF{alpha} production has been implicated in the regulation of inflammation and contributes to the effectiveness of type I IFNs in the treatment of certain autoimmune and inflammatory diseases. In this study, we investigated mechanisms by which type I IFNs suppress induction of TNF{alpha} production by immune complexes, Fc receptors, and Toll-like receptors. Suppression of TNF{alpha} production was mediated by induction and activation of the Axl receptor tyrosine kinase and downstream induction of Twist transcriptional repressors that bind to E box elements in the TNF promoter and suppress NF-{kappa}B–dependent transcription. Twist expression was activated by the Axl ligand Gas6 and by protein S and apoptotic cells. These results implicate Twist proteins in regulation of TNF{alpha} production by antiinflammatory factors and pathways, and provide a mechanism by which type I IFNs and Axl receptors suppress inflammatory cytokine production.


Abbreviations used: bHLH, basic helix loop helix; ChIP, chromatin immunoprecipitation; ERK, extracellular signal–regulated kinase; MAPK, mitogen-activated protein kinase; SLE, systemic lupus erythematosus.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS